VOSEVI FDA approval date

The FDA approved VOSEVI on 18 Jul 2017.

FDA approval date
18 Jul 2017

Drug identity has not yet been verified against registry records

Also recorded as SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-07-18DayVOSEVIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209195", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["VOSEVI"], "active_ingredients": ["SOFOSBUVIR", "VELPATASVIR", "VOXILAPREVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170718", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026